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Introduction
In this paper, we will address the use of strategic litigation 
to access health care services from an ethical perspective, 
considering aspects of justice and distributive justice. Liti-
gation has been a strategy that individuals and groups, 
including grassroots movements and holders of public 
offices in the judiciary and the legislative branches, have 
resorted to in an effort to achieve some form of health 
justice at both the individual and social level. This has 
increased the role of the courts in pressuring the execu-
tive body’s ability to manage the health system, especially 
in those countries with national public health systems 
and a web of policies to guarantee access to social services. 
Scholars argue that courts point out the political failures 
and executive mismanagement in upholding social rights, 
allowing a gap that will be filled by the judiciary branch. 
Courts would act for the legal enforcement of health care 
in several ways, and the most common are: (1) individual 
enforcement in which courts rule to grant access to some 
benefits guaranteed by social rights to a single plaintiff; 
(2) negative injunction through which courts act to strike 
down benefits cuts or other laws that decrease or end 
social benefits; (3) structural enforcement through which 
courts act to guarantee a collective appeal from one or 
more cases that represent this collective request and thus 
lead to creation of policies with structural impact [1]. 
When one thinks of these three forms of legal enforce-
ment in the context of accessing medical care and health-
related policies, it is apparent that each one leads to 
different impacts on the health care system. However, it 
is difficult to measure the positive impacts because often 
enough, while a court decision has an immediate positive 
impact on the life of a single individual, the plaintiff, or 
on a particular social group, this generates a social-struc-
tural problem for the allocation of public resources that 
this court decision demands from the executive body. 
However, there are situations in which the court’s ruling 
forces the executive and legislative branches to create new 
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Background: Some scholars and global health advocates argue that litigation is a strategy to advance 
public health care, especially in those countries that do not have specific legislation to guarantee access 
to basic health care services. However, strategic litigation has another side, known as judicialization of 
the right to health, particularly present in the Latin American region where most countries incorporate 
the right to health into their constitutions, but their citizens still struggle with health disparities.
Objectives: Considering these two perspectives on litigation in health care, this paper examines the phe-
nomenon of litigation in health care and its impact on public health in Brazil, where there is an ambiguous 
process of litigation in health care. 
Methods: Comparing the literature of both the use of strategic litigation for advancing public health 
and the judicialization of the right to health, this paper develops an ethical analysis of the impacts of 
strategic litigation for individuals and societies, using Brazil’s public health care system and its policies as 
case-study of the impact of court decisions on the management of the system. 
Findings: Supporters of strategic litigation present experiences in African countries using this strategy 
to access a specific medical service led to enforce the creation of health-related policies by authorities 
and policymakers. However, in Brazil, a country with the right to health guaranteed by its Constitution, 
strategic litigation creates access to health care for some individuals, but also results in complex socio-
medical challenges with significant impact for public administration and distributive justice.
Conclusions: Strategic litigation can lead to ambiguous results, which will depend on the local context and 
the existence or not of public health services and health-related policies. When this strategy is consid-
ered, ethical analysis helps to understand how litigation can both benefit and damage individuals’ health 
and the public health system in the complex context and diverse reality of Brazil. As a result, strategic 
litigation must be considered from an ethical perspective of prudence and discernment in a close interac-
tion with the local reality, its particular circumstances, culture, policies, and laws.
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policies and/or change strategies, priorities, and rethink 
public management. In this case, the result will be a struc-
tural shift to make a public good, such as health care, a 
right with new ways of accessibility. 
The ambiguity of the impact of litigation on health care 
raises questions on the benefits of strategic litigation in 
global public health in terms of accessing justice by a sin-
gle individual and distributive justice created by socioeco-
nomic and political structures. Thereby, this is the central 
question of this paper: is strategic litigation an ally or an 
enemy of global public health? Our goal is not to submit a 
yes or no answer to this question. Perhaps this would only 
be possible in an abstract account, but it would require 
one to pick a side in their approach to justice, choosing 
between who or what takes priority: the need of a single 
individual or the maintenance of the social body prioritiz-
ing the collective. As we neither dismiss the health care 
needs of the individual nor the necessity of a sustain-
able public health system, we won’t suggest an abstract 
approach, but rather guide our account through concrete 
examples of strategic litigations and their consequences. 
Thus, we argue that litigation in health care must be con-
sidered in different ways depending on the reality and 
the local laws (or lack thereof) of each particular area. 
The reality of a country and its health-related laws would 
require different ways to address litigation as a positive or 
negative strategy for health care access by individuals and 
distributive justice.
Litigation and Fairness
Supporters of litigation as a mechanism to advance access 
to health care stress that court decisions force the crea-
tion of laws and policies to guarantee access to medical 
services in countries that do not have specific legislation. 
Some also affirm that, even in countries that have health-
related legislation and a public system, litigation forces 
to improve the system, to expand access, and to create 
institutions to improve public management. These two 
arguments must be placed in a context to make more 
sense because they are two different uses of litigation in 
distinct health contexts. 
The first is the use of litigation in those countries with 
either no health-related policies and health system, or 
their policies and system are very limited, that is, many 
services related to health are not covered (this would 
be the case of a country with a public system that pro-
vides primary care, but it does not cover HIV medication, 
while its population has many cases of HIV infection). 
Considering this context, Tamar Ezer and Priti Patel argue 
that litigation is a strategy to advance public health care, 
especially in those countries that do not have specific 
legislation to guarantee their people access to basic 
health care services. Their argument relies on experi-
ences in African countries that used “strategic litigation 
as an important tool to develop and enforce legal protec-
tions critical to health [2].” This strategy was important 
to join different social sectors, such as grassroots move-
ments, media and health professionals, to influence poli-
cies, law, and practices that advance public health, with 
particular success in the context of HIV. Ezer and Patel 
narrow their definition of strategic litigation by using the 
perspective of litigation as “an intended impact beyond a 
particular case to influence broader change at the level 
of law, policy, practice, or social discourse [2].” This broad 
impact occurs when strategic litigation does not operate 
alone and isolated in the courts. Strategic litigation needs 
partners to raise the visibility of the case and thus create 
a public debate. With visibility, a litigation demonstrates 
that what an individual is requesting could be a right to 
a good that everyone should access, benefiting the devel-
opment of the society. One example of this occurred in 
the context of HIV in South Africa. “The classic case is 
Minister of Health v. Treatment Action Campaign, where 
the Constitutional Court of South Africa required the 
government to provide medication to prevent mother-to-
child transmission of HIV and reversed the government’s 
policy of denying necessary medication to pregnant 
HIV-positive women [2].” Similar processes of strategic 
litigation occurred in other African countries, such as 
Botswana, Kenya, and Malawi.
We also want to mention a positive impact of strategic 
litigation in Brazil, a country with an extreme increase of 
health litigation in recent years. Although Brazil institu-
tionalized a health program for HIV in 1986, this program 
became a reality with free distribution of medications 
in 1996, after years of mobilizing the civil society and 
many lawsuits against the government for accessing HIV 
medication. This mobilization and strategic litigation 
were possible because the democratization of the country 
and the promulgation of the right to health as a consti-
tutional mandate [3]. As a case study, Brazil shows that 
litigation has functioned to disturb the balance between 
public budgets and distributive justice in health. However, 
there are arguments suggesting that litigation in Brazil 
has also had positive impact. Danielle da Costa L. Borges, 
for example, argues: “Individual litigation for health care 
rights in Brazil has pushed forward policy changes that 
range from strengthening health technology and assess-
ment processes to better health care governance through 
institutional dialogue between different state actors [3].” 
Borges demonstrates that the high number of litigations 
and court decisions in Brazil have forced public authori-
ties from all bodies of government to work in collabora-
tion among themselves and with public health experts. 
This led to the creation of institutions to help judges, 
prosecutor’s offices, and attorneys access technical advice 
regarding health needs and requests. Additionally, these 
institutions (e.g. CONITEC, NAT) also support public 
authorities and managers in the administration of the 
public health system and in the improvement of health 
services assessments [4]. This collaboration has shaped 
new forms of governance and decreased the number of lit-
igations in the States that have used these institutions [5]. 
However, the concern raised here is that these new forms 
of collaboration and strategies have not improved access 
to health care services for those individuals who feel mar-
ginalized from the system; instead, they only created a 
kind of bureaucracy that prevents these individuals from 
bringing lawsuits against their local, state, and federal 
governments. Consequently, individuals do not access 
some sort of justice, and the necessity to improve dis-
tributive justice is ignored. 
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Litigation and Distributive Justice: The Case of 
Brazil
To understand the phenomenon of litigation or 
judicialization of health care in Brazil, one needs to be 
aware of the Brazilian health system and the federal laws 
regulating it [6]. The Constitution of 1988, created after 25 
year of dictatorship, states health as a right of all and the 
duty of the state is to guarantee that all people in Brazilian 
territory have access to the benefit that this right creates 
[7]. Following the Constitution, the Leis Orgânicas de 
Saúde 8.080/90 and 8.142/90 created the Unified Health 
System (SUS) based on the principles of universality, 
integrality, and equity, with social-participation, shared 
funding responsibility, and decentralized management 
[8, 9]. The universal and integral access to health care in 
Brazil opens a large avenue for the judicialization of the 
right to health when public authorities fail to fulfill their 
obligations. In practical terms, this means that someone 
who needs a medical service or a medication and is unable 
to obtain it in the public service would have to fight to 
access the service through a court decision. The main rea-
son that makes this lawsuit possible – for a person who 
cannot receive the medical care he/she needs and judges 
to rule in his/her favor – is the Article 196 of Federal Con-
stitution.
According to the National Council of Justice (CNJ), in 
2016 Brazil had more than 300 thousand lawsuits related 
to the right to health [10, 11]. In a study published by 
Ribeiro and Hartmann, the main characteristics of the 
judicialization of the right to health are: “Judicial claims 
are individual, not collective; Most cases request the provi-
sion of drugs through SUS; Claims have a success rate of 
90%; [and] Favorable rulings are not based on independ-
ent medical assessments, but rather on prescriptions of 
the plaintiffs’ physicians [12].”
There is an enormous and disorderly growth of legal 
actions in the last few years in all levels of the Brazilian 
juridical system. For example, in the last 10 years, only the 
Supreme Court had more than 3,800 lawsuits to judge 
[12]. This caused scholars from diverse fields, especially 
scholars from public health, public policies, and law, to 
study this phenomenon. The literature shows that the 
precarious situation of the SUS, which creates problems 
for people to access healthcare services, is the main 
cause leading patients and families to bring lawsuits to 
the courts [11, 13]. It seems obvious that if a sick person 
needs medical services and the public system cannot 
meet his/her need, this person will bring a lawsuit to the 
court to have his/her right to health care guaranteed. 
Another reason for these lawsuits is to access a kind of 
health care that the SUS does not provide. This is specifi-
cally prevalent in the case of accessing medications. The 
SUS has a long list of medications that are provided to 
the population as part of the citizens’ right to health. 
However, in some cases someone needs a medication that 
is not provided by the SUS, because it is not yet available 
in Brazil or because it is very expensive. Studies show that 
most lawsuits concern a need to obtaining medications, 
with the majority requesting medications of high cost, 
including those that are not part of governmental drug 
formularies [14, 15].
The case of Brazil shows that strategic litigation creates 
an ethical dilemma between the need of an individual 
and distributive justice. On the one hand, a lawsuit can 
guarantee that a person has what he/she needs, and it is 
his/her right, a constitutional right. On the other hand, 
scholars who are dedicated to this issue in Brazil seem to 
agree that the judicialization of the right to health cre-
ates an extra-expenditure for public administrations that 
was not part of their budget. As a result, judicialization 
has a tremendous impact on the distribution of resources 
in society [12, 15]. Biehl and Petryna even argue that 
“although lawsuits secure access for thousands of people, 
at least temporarily, this judicialization of the right to 
health generates intensely complex sociomedical realities 
and significant administrative and fiscal challenges which, 
officials argue, have the potential to widen inequalities in 
health care delivery [16].”
Nevertheless, when the political, legislative, and 
executive powers cannot create policies and implement 
actions and strategies to fulfill their obligation to guaran-
tee healthcare services for the population, the judiciary 
power is activated to create access to a fundamental right 
protected by the Constitution. According to Costa, Motto, 
and Araújo, the judicialization to the right to health 
“justifies itself because, in the constitutional and infra-
constitutional dimensions of this right in a context of the 
precarious reality of the Brazilian health, the Judiciary has 
the responsibility of defining guidelines for offering this 
public service [14].” And they add: “the Judiciary assumed 
the role of guaranteeing the exercise, implementation, 
and concretization of individual and fundamental rights, 
explicitly stated in the Constitution, when the executive 
and legislative powers are negligent [14].”
The previous and current administrations have issued 
policies favoring the private health sector [17]. These neo-
liberal policies created a process of dismantling the SUS 
and all its health policies [18] that aimed to guarantee the 
right to health established by the Brazilian Constitution. 
With a non-functioning public healthcare system, access 
to medical services tends to decrease, creating many 
obstacles for people to access services they need and mar-
ginalizing many others from their rights. This situation 
forces people to use the courts in order to have their rights 
honored. Consequently, the problem of judicialization of 
the right to health tends to multiply its cases every day. 
While health policies do not shift to a direction that pro-
motes the expansion and strengthening of the SUS, courts 
will fulfill the gap left by the negligence of the legislative 
and executive powers, creating more challenges for public 
managers, people in need of healthcare assistance, and 
the society as a whole, especially for those who are poor 
and marginalized. 
Conclusion
As we stated at the beginning of this essay, we did not 
intend to provide a yes or no answer for the question 
“is strategic litigation an ally or enemy for global public 
health?” We endeavored to demonstrate that there are 
situations in which litigation in health care generates a 
positive social impact by favoring the creation of health-
related policies that promote access to health care and 
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even structural changes. As a result, distributive justice 
advances. However, there are other cases in which litiga-
tion made justice possible for an individual, but disturbed 
the system, backsliding distributive justice. More studies 
are needed to provide substantial data on the impact of 
litigation on people’s lives and health care systems. How-
ever, we argue that litigation in health care has two faces: 
one can be positive for single individuals and negative 
for the sustainability of the system, and another can be 
positive for both by promoting the development of the 
health care system and more accessibility to individuals. 
Therefore, strategic litigation must be considered from a 
perspective of prudence and discernment in close inter-
action with the local reality, its particular circumstances, 
culture, policies, and laws.
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